403 related articles for article (PubMed ID: 9070653)
1. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
Somasundaram K; El-Deiry WS
Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
[TBL] [Abstract][Full Text] [Related]
2. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
3. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
4. E1A physically interacts with RUNX3 and inhibits its transactivation activity.
Cha EJ; Oh BC; Wee HJ; Chi XZ; Goh YM; Lee KS; Ito Y; Bae SC
J Cell Biochem; 2008 Sep; 105(1):236-44. PubMed ID: 18570183
[TBL] [Abstract][Full Text] [Related]
5. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
[TBL] [Abstract][Full Text] [Related]
6. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
7. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
Sang N; Avantaggiati ML; Giordano A
J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
9. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53.
Zhang X; Grand RJ; McCabe CJ; Franklyn JA; Gallimore PH; Turnell AS
Biochem J; 2002 Nov; 368(Pt 1):191-201. PubMed ID: 12164786
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation.
Kawasaki H; Eckner R; Yao TP; Taira K; Chiu R; Livingston DM; Yokoyama KK
Nature; 1998 May; 393(6682):284-9. PubMed ID: 9607768
[TBL] [Abstract][Full Text] [Related]
12. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
Das S; El-Deiry WS; Somasundaram K
J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
[TBL] [Abstract][Full Text] [Related]
14. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
Savelyeva I; Dobbelstein M
Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
16. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
Liu SL; Rand A; Kelm RJ; Getz MJ
Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
[TBL] [Abstract][Full Text] [Related]
17. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
[TBL] [Abstract][Full Text] [Related]
18. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
Hansen RS; Braithwaite AW
Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
[TBL] [Abstract][Full Text] [Related]
19. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.
Scolnick DM; Chehab NH; Stavridi ES; Lien MC; Caruso L; Moran E; Berger SL; Halazonetis TD
Cancer Res; 1997 Sep; 57(17):3693-6. PubMed ID: 9288775
[TBL] [Abstract][Full Text] [Related]
20. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
